GL1X · GenesisL1 explorer

UniProt P28063

Proteasome subunit beta type-8,Proteasome subunit beta type-5 (P28063)

Proteasome subunit beta type-8,Proteasome subunit beta type-5 (UniProt P28063), EC 3.4.25.1: 19 experimental structures on GenesisL1, 9 ligands bound, 10 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P28063
Protein
Proteasome subunit beta type-8,Proteasome subunit beta type-5
EC
3.4.25.1
Experimental structures
19
Predicted models
0
Ligands
9
Pockets
10 · 3 records with a druggable one

Structures

19 records of P28063 in the MolNFT archive: 19 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3UNHMouse 20S immunoproteasomex-ray diffractionK, Y——
3UNHMouse 20S immunoproteasomex-ray diffractionK, Y——
5L65Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 3BV—
5L65Yeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 3BV—
5L66Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, BO23 (best 0.78)
5L66Yeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, BO2—
5L67Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 39V3 (best 0.78)
5L67Yeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 39V—
5L68Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 6N5—
5L68Yeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 6N5—
5L69Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 79P4 (best 0.78)
5L69Yeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 79P—
5L6AYeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 79L—
5L6AYeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 79L—
5L6BYeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 04C—
5L6BYeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 04C—
5L6CYeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with…x-ray diffractionK, YMG, 6NV—
5L6CYeast 20S proteasome with mouse BETA5I (1-138) and mouse BETA6 (97- 111; 118-133) in complex with…x-ray diffractionK, YMG, 6NV—
P28063AlphaFold monomer V2.0 prediction for proteasome subunit beta type-8 (P28063)———

Ligands

  • MG · Magnesium ion · in 16 records
  • 04C · 1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol · in 2 records
  • 39V · N-[(3-methyl-1H-inden-2-yl)carbonyl]-D-alanyl-N-[(2S, 4R)-5-hydroxy-4-methyl-3-oxo-1-phenylpentan-2-yl]-L-tryptophanamide · in 2 records
  • 3BV · N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide · in 2 records
  • 6N5 · ~{N}-[(2~{S})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide · in 2 records
  • 6NV · ~{N}-[(2~{R})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide · in 2 records
  • 79L · (2~{S})-3-(4-methoxyphenyl)-~{N}-[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]-2-[[(2~{R})-2-(2-morpholin-4-ylethanoylamino) propanoyl]amino]propanamide · in 2 records
  • 79P · (2~{S})-3-(1~{H}-indol-3-yl)-~{N}-[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]-2-[[(2~{R})-2-(2-morpholin-4-ylethanoylamino) propanoyl]amino]propanamide · in 2 records
  • BO2 · N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.